272 related articles for article (PubMed ID: 25230853)
1. Nanoparticulate carriers: an emerging tool for breast cancer therapy.
Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R
J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting.
Mehra NK; Jain NK
J Drug Target; 2016; 24(4):294-308. PubMed ID: 26147085
[TBL] [Abstract][Full Text] [Related]
3. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in nanotechnology for cancer therapy.
Tang MF; Lei L; Guo SR; Huang WL
Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
Prakash S; Malhotra M; Shao W; Tomaro-Duchesneau C; Abbasi S
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1340-51. PubMed ID: 21756952
[TBL] [Abstract][Full Text] [Related]
6. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
7. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
10. Inorganic nanoparticles for cancer imaging and therapy.
Huang HC; Barua S; Sharma G; Dey SK; Rege K
J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
[TBL] [Abstract][Full Text] [Related]
11. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
14. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles: recent progress in cancer therapeutics.
Seeta Rama Raju G; Benton L; Pavitra E; Yu JS
Chem Commun (Camb); 2015 Sep; 51(68):13248-59. PubMed ID: 26234539
[TBL] [Abstract][Full Text] [Related]
16. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
[TBL] [Abstract][Full Text] [Related]
17. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
18. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles as tools to study and control stem cells.
Ferreira L
J Cell Biochem; 2009 Nov; 108(4):746-52. PubMed ID: 19708027
[TBL] [Abstract][Full Text] [Related]
20. Dendrimers in oncology: an expanding horizon.
Tekade RK; Kumar PV; Jain NK
Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
